TITLE

Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment

AUTHOR(S)
Rajkumar, S. Vincent; Dispenzieri, Angela; Kyle, Robert A.
PUB. DATE
May 2006
SOURCE
Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p693
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The spectrum of plasma cell disorders Is broad. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma are asymptomatic disorders characterized by monoclonal plasma cell proliferation in the bone marrow in the absence of end-organ damage. Waldenström macroglobulinemia typically involves an ontogenically less mature lymphoplasmacytic bone marrow cell and is characterized by secretion of a monoclonal IgM protein. Solitary plasmacytoma is the only known potentially curable plasma cell disorder. Finally, AL (immunoglobulin light chain) amyloidosis and POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome are disorders characterized by low tumor burden but profound multisystemic disease. Updated diagnostic criteria for these disorders, risk stratification models to determine prognosis, and the current management of these diverse entitles are discussed in this review.
ACCESSION #
21258744

 

Related Articles

  • CORRECTIONS.  // Mayo Clinic Proceedings;Nov2006, Vol. 81 Issue 11, p1509 

    Two corrections to the articles "Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment," that was published in the May 2006 issue and "Oncologic Emergencies: Diagnosis and Treatment," that...

  • Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays. Katzmann, Jerry A.; Dispenzieri, Angela; Kyle, Robert A.; Snyder, Melissa R.; Plevak, Matthew F.; Larson, Dirk R.; Abraham, Roshini S.; Lust, John A.; Melton III, L. Joseph; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1575 

    OBJECTIVE: To determine the relative diagnostic contribution of urine assays as part of the screening algorithm for monoclonal gammopathies. PATIENTS AND METHODS: We Identified 428 patients with a monoclonal gammopathy and monoclonal urinary protein at initial diagnosis of plasma cell dyscrasia...

  • Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Wang, Chen; Su, Wei; Zhang, Wei; Di, Qian; Duan, Ming-Hui; Ji, Wei; Cao, Xin-Xin; Zhou, Dao-Bin; Li, Jian // Annals of Hematology;Jul2014, Vol. 93 Issue 7, p1201 

    POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare plasma cell dyscrasia. Nearly all patients present with a λ-restricted monoclonal gammopathy. Most patients with POEMS syndrome have been reported to have a normal serum free light...

  • MGUS preceded nearly all multiple myelomas.  // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p30 

    The article deals with two studies which found that premalignant plasma cell disorder monoclonal gammopathy of undetermined significant almost always preceded the development of multiple myeloma.

  • Progression Risk for Smoldering Myeloma. Artz, Andrew // Clinical Oncology Alert;Aug2007, Vol. 23 Issue 8, p59 

    MONOCLONAL GAMMOPATHIES ENCOMPASS A spectrum of disorders related to a clonal proliferation of plasma cells. Although not necessarily distinct entities, diagnostic criteria separate monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma. To diagnose...

  • Overview: Multiple lines of attack. Graham-Rowe, Duncan // Nature;12/15/2011 Supplement, Vol. 480 Issue 7377, pS34 

    The article offers information on the mechanism and treatment for multiple myeloma. It says that myeloma crowd out healthy plasma cells and interferes the production of other blood cell types and those involved in bone regeneration. It adds that the disease starts as a monoclonal gammopathy of...

  • Treatment of dysimmune neuropathies. Nobile-Orazio, Eduardo // Journal of Neurology;Apr2005, Vol. 252 Issue 4, p385 

    IVIg and PE are similarly effective in accelerating the recovery but there is still little evidence that they can reduce mortality or long-term disability. Recent reports on the association of intravenous methylprednisolone or interferon-ß (IFN-ß) to IVIg did not result in significant...

  • Monoclonal Gammopathy of Undetermined Significance. Bladé, Joan // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2765 

    The article discusses the diagnosis, evaluation, and treatment of a patient with the clinical problem monoclonal gammopathy of undetermined significance (MGUS). An overview of MGUS is presented along with various statistical information related to its prevalence and progression. The author...

  • Multiple myeloma with primary amyloidosis. Nair, D. A.; Mehta, A.; Mikhailidis, D. P.; Winder, A. F. // Journal of the Royal Society of Medicine;Sep1997, Vol. 90 Issue 9, p502 

    The article describes a case which illustrates some of the laboratory findings that differentiate primary amyloidosis from multiple myeloma. The case was of a woman aged 60 who complained of a painful shoulder and arm. Biochemical and haemato logical diagnosis revealed nothing. Three months...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics